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Abstract
Introduction: Gastrointestinal stromal tumor is the most frequent nonepithelial tumor found in the gastrointestinal
tract. One important clinical problem is that gastrointestinal stromal tumors, especially the extramural growth type,
can be difficult to distinguish from other organ tumors. The case of a patient with an extramural gastrointestinal
stromal tumor of the duodenum that mimicked a pancreatic head tumor has previously been reported. Here, we
report a rare case of a patient with a duodenal gastrointestinal stromal tumor with extramural growth that
mimicked a pancreatic neuroendocrine tumor. In this case, the gastrointestinal stromal tumor was also associated
with neurofibromatosis type 1 (also known as von Recklinghausen’s disease). To the best of our knowledge, this is
the first report to describe the case of a patient with a duodenal gastrointestinal stromal tumor with
neurofibromatosis type 1 in which the radiological findings resembled those of a pancreatic neuroendocrine
tumor.
Case presentation: A 60-year-old Japanese woman with a history of neurofibromatosis type 1 was admitted to
our hospital for the treatment of a tumor of her pancreas. She had no symptoms, but an abdominal
ultrasonography screening examination had revealed a hypoechoic mass in the head of her pancreas. Laboratory
data, including tumor markers, were within the normal ranges, and her insulin and glucagon levels were also
within the normal ranges. However, her plasma gastrin level was elevated at 580 pg/mL (30 to 150 pg/mL).
A computed tomography examination revealed a hypervascular tumor measuring 14 mm in diameter in the head
of her pancreas. We diagnosed the patient as having a pancreatic neuroendocrine tumor and performed a tumor
resection with a duodenal wedge resection. Microscopic analysis revealed spindle cell tumors in a trabecular
pattern. The patient was finally diagnosed as having a duodenal gastrointestinal stromal tumor of the
uncommitted type.
Conclusion: Extramural growth-type gastrointestinal stromal tumors can be difficult to distinguish from other
organ tumors. In our case, a duodenal gastrointestinal stromal tumor was difficult to distinguish from a pancreatic
neuroendocrine tumor based on radiological findings. When patients are identified as having hypervascular lesions
that have adhered to the gastrointestinal tract, the possibility of an extramural growth-type gastrointestinal stromal
tumor as a differential diagnosis should be considered in patients with neurofibromatosis type 1.
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Introduction
Gastrointestinal stromal tumor (GIST) is the nonepithelial
tumor that occurs most frequently in the gastrointestinal
tract. One important clinical problem is that GIST, in
particular the extramural growth type, can be difficult to
distinguish from other organ tumors. In particular, duode-
nal extramural GIST is difficult to distinguish from a pan-
creatic tumor. In 2005, Uchida et al. first reported the case
of a patient with an extramural GIST of the duodenum
that had mimicked a tumor of the pancreatic head [1].
Here, we report a rare case of a patient with duodenal
extramural growth-type GIST that was associated with
neurofibromatosis type 1 (NF1; also known as von Reck-
linghausen’s disease). NF1-associated gastrointestinal
lesions include not only GIST, but also hyperplastic lesions
of intestinal neural tissue and its supporting structures and
endocrine cell tumors of the duodenum and periampullary
regions [2]. Our case described here was rare and difficult
to distinguish from a pancreatic neuroendocrine tumor
based on radiological findings and etiological features.
Case presentation
A 60-year-old Japanese woman with a history of rheu-
matoid arthritis and NF1 was admitted to our hospital
for the treatment of a tumor of a pancreas. She had no
symptoms, but an abdominal ultrasonography screening
examination had revealed a hypoechoic mass in the
head of a pancreas. Laboratory data, including measure-
ment of tumor markers, were within the normal ranges,
and her insulin and glucagon levels were also within the
normal ranges. However, the plasma gastrin level was
elevated at 580 pg/mL (30 to 150 pg/mL). A computed
tomography (CT) examination revealed a hypervascular
tumor measuring 14 mm in diameter in the pancreas
head (Figure 1). Magnetic resonance imaging (MRI) also
revealed a massive tumor in the head of the pancreas.
A duodenal endoscopy revealed that the lumen of the
patient’s duodenum was not compressed by the extra-
luminal tumor, and findings on endoscopic retrograde
cholangiopancreatography showed that her main pan-
creatic duct was not stenosed or blocked. We diagnosed
the patient as having a pancreatic neuroendocrine
tumor and planned to perform a tumoral enucleation
from her pancreas.
A whitish elastic hard nodule was easily removed from
the pancreatic parenchyma, but the tumor was con-
nected to her duodenal wall via a stalk. Consequently,
we performed a tumor resection with a duodenal wedge
resection. As a small whitish nodule was also found in
the patient’s jejunum during the initial operation, a seg-
mental jejunectomy was also performed. A histological
examination of frozen sections of the patient’s tumors
revealed spindle cells with connective tissues. Thus, we
diagnosed the patient as having multiple GISTs and did
not perform a more radical resection.
Macroscopically, the resected specimens consisted of
solid and hard masses that were connected to the
patient’s duodenal and jejunal walls but not to the par-
enchyma of the head of her pancreas. Microscopically,
this neoplasm originated from the muscularis propria of
the duodenum wall and consisted of spindle cells in a
trabecular pattern without necrosis (Figure 2). Less than
five mitoses per 50 high-power fields were observed.
On immunohistochemistry, both of the patient’s
tumors were diffusely positive for the type III receptor
tyrosine kinase (TK) named KIT (Dako Cytomation,
Copenhagen, Denmark; Figure 3), whereas her duodenal
tumor was focally positive and her jejunal tumor was
diffusely positive for CD34 (Nichirei, Tokyo, Japan).
Both of the patient’s tumors were negative for smooth
Figure 1 An enhanced computed tomography scan revealing a
hypervascular tumor in the head of the patient’s pancreas
(arrow).
Figure 2 Microscopic appearance of the tumor. Stained with
hematoxylin and eosin. Magnification × 100.
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muscle actin (Dako Cytomation, Copenhagen, Denmark)
and S-100 (Nichirei, Tokyo, Japan). We finally diagnosed
the patient as having duodenal and jejunal GISTs of
uncommitted type. Patients with these GISTs are
regarded as being very low risk of recurrence according
to the National Comprehensive Cancer Network
(NCCN) guidelines [3]. The patient has remained
healthy for two years without any recurrences after
surgery.
Discussion
GISTs are the most frequently occurring nonepithelial
tumor of the gastrointestinal tract. Based on the recent
discovery that GIST and the intestinal cell of Cajal
(ICC) express CD34 and KIT, GISTs are now consid-
ered to develop from ICC or to differentiate into ICC.
Most GISTs carry mutations in the proto-oncogene c-
kit, which constitutively activates KIT kinase when
translated; this gain-of-function mutation in the c-kit
gene is considered to be the cause of GISTs [4]. After
the stomach, the small intestine is the second most
common primary site for GISTs. Miettinen et al. [5]
reported that duodenal GISTs most frequently involve
the second portion of the duodenum, followed by the
third, fourth, and first portions. They also reported that
many tumors are comprised of a gross ulceration of the
mucosa, with a component that bulged underneath the
mucosa, forming a partly intramural mass with a cen-
trally ulcerated umbilication.
In our case report, the patient’s tumor exhibited only
extramural growth, and no specific intramural change in
the duodenum was present. These clinical features are
rare [5], so it was difficult for us to distinguish a GIST
from a tumor of the pancreas. Therefore, we first con-
sidered this tumor to be a neuroendocrine tumor in the
head of the patient’s pancreas, based on the tumors
radiological and duodenal endoscopic findings [6]. CT
studies indicated that GISTs are hypervascular and may
have cystic and necrotic components combined with
intramural and extramural tumor growth and signs of
malignancy. Small tumors are depicted on CT scans as
sharply marginated smooth masses with moderate con-
trast enhancement [7]. In our case report, the patient’s
radiological findings were typical of a GIST, but the
extramural growth made it difficult to distinguish the
GIST from other types of tumors, especially a pancreatic
neuroendocrine tumor. Furthermore, the patient’s
plasma gastrin level was slightly elevated. Consequently,
we misdiagnosed this tumor as a gastrinoma. However,
the immunohistochemical features of both tumors (duo-
denum and jejunum) were diffusely negative for gastrin.
Furthermore, almost all gastrinomas are located in the
“gastrinoma triangle”. We carefully examined this area,
but no other tumors were observed. After tumor resec-
tion, the plasma gastrin level did not change. The
plasma gastrin level might have been slightly elevated in
this case as a result of atrophic gastritis. In fact, an
upper endoscopy and biopsy specimen revealed severe
atrophic gastritis. Because of the absence of acid inhibi-
tion, the functional G cells were stimulated and gastrin
secretion was increased [8].
NF1 is caused by a mutation of the NF1 gene, but the
mutations are heterogeneous and the diagnosis of NF1
is still based largely on clinical criteria. Many patients
with NF1 will have a GIST, because it occurs in
approximately 11 to 25% of all NF1 patients [9]. Spora-
dic GISTs are most commonly found in the stomach
and contain mutated KIT or plate-derived growth factor
receptor (PDGFR) protein; point mutations in the c-kit
or PDGFR genes have also been identified. However,
NF1 that is associated with GIST is rarely associated
with these other mutations, and multiple GISTs are
commonly found in the small intestine. The histologic
and immunohistochemical differences between GISTs in
NF1 patients and non-NF1 patients have not been fully
clarified.
According to the NCCN guidelines [3], the GISTs in
our case were associated with a very low risk of recur-
rence and the patient should be followed up every six
months with a CT scan. No obvious evidence exists that
adjuvant chemotherapy for resected GISTs might pro-
long the post-operative survival times of patients. Thus,
our case was not treated with adjuvant imatinib therapy
but was followed up every six months with CT for two
years. Fortunately, no new tumors were observed in this
time.
The most important issue in surgical strategies for
patients with GIST is whether a complete resection can
be achieved. A variety of surgical methods can be used
Figure 3 Microscopic appearance of the tumor. c-kit
immunohistochemistry. Magnification × 100.
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to obtain a complete resection, such as duodenopan-
createctomy, duodenal wedge resection, and segmental
duodenal resection. However, in this very low-risk group
of completely resectable GISTs, tumor resection with a
duodenal wedge resection and segmental jejunectomy
might be suitable surgical methods.
NF1-associated gastrointestinal lesions include not
only GISTs, but also hyperplastic lesions of intestinal
neural tissue and its supporting structures, and endo-
crine cell tumors of the duodenum and periampullary
region [2]. In our case, a duodenal GIST was difficult to
distinguish from a periampullary endocrine tumor based
not only on the radiological findings, but also the etiolo-
gical features.
Conclusions
A rare and difficult case of duodenal extramural GIST
associated with NF1 is presented. Duodenal extramural
growth GISTs are difficult to distinguish from pancrea-
tic neuroendocrine tumors, especially in patients with
NF1.
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